Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans.
J Autoimmun. 1997 Oct;10(5):479-89. Unique Identifier : AIDSLINE /MED98018742 Raju R; Navaneetham D; Kellermann SA; Freeman SL; Morris JC; McCormick DJ; Conti-Fine BM; Department of Biochemistry, University of Minnesota, St Paul, MN; 55108, USA.
Abstract:
Healthy humans have CD4+ T cells specific for self-components. Since autoreactive T cells in autoimmune patients may use a limited number of TCR V-region genes, we investigated here whether this also occurs for the potentially autoreactive CD4+ cells present in healthy persons. We studied CD4+ cells specific for human TSH receptor (TSHr) sequences, that are present with high frequency in healthy subjects and, as expected, in Graves' disease (GD) patients. We used short-term CD4+ cell lines propagated from four GD patients and five healthy subjects by cycles of stimulation with a pool of overlapping synthetic peptides corresponding to the putative extracellular parts of the TSHr sequence. The lines recognized the pool of TSHr peptides specifically and vigorously. Their epitope repertoire had been characterized previously: each line recognized one or a few TSHr peptides, different for each subject.We determined their TCR Vbeta usage by a semi-quantitative reverse transcriptase PCR assay, using primers specific for each known human Vbeta region family, in conjunction with a constant region primer. Six lines preferentially used one Vbeta family (42-94%), different for each line. In all lines, three or less Vbeta families accounted for approximately 60% or more of the Vbeta usage. Different Vbeta regions were used by each subject. There was no obvious difference between the Vbeta usage of the lines from GD patients and healthy controls.These results suggest that a limited pool of potentially autoreactive T cells survives clonal deletion. The pathogenic CD4+ cells involved in autoimmune diseases are likely recruited from that pool, since they have similar characteristics of epitope and TCR repertoire as the CD4+ cells specific for the same autoantigen in healthy subjects. Copyright 1997 Academic Press Limited.
Keywords: *CD4-Positive T-Lymphocytes/IMMUNOLOGY *CD4-Positive T-Lymphocytes/ULTRASTRUCTURE *Graves' Disease/IMMUNOLOGY *Receptors, Antigen, T-Cell, alpha-beta/IMMUNOLOGY *Receptors, Thyrotropin/IMMUNOLOGY 980130
M9811098
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
